Syed O Hasan
Examiner (ID: 9396, Phone: (571)272-0990 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3783, 3747 |
Total Applications | 907 |
Issued Applications | 710 |
Pending Applications | 53 |
Abandoned Applications | 143 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16704321
[patent_doc_number] => 10954241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Heterocyclic compounds as ret kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/093854
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38427
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093854 | Heterocyclic compounds as ret kinase inhibitors | Apr 17, 2017 | Issued |
Array
(
[id] => 16756483
[patent_doc_number] => 10975019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Inhibitors of meprin a and b
[patent_app_type] => utility
[patent_app_number] => 16/094460
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14062
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094460 | Inhibitors of meprin a and b | Apr 17, 2017 | Issued |
Array
(
[id] => 17043750
[patent_doc_number] => 11096909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Compounds for use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/091551
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6535
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091551 | Compounds for use in the treatment of cancer | Apr 5, 2017 | Issued |
Array
(
[id] => 11757222
[patent_doc_number] => 20170204091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES'
[patent_app_type] => utility
[patent_app_number] => 15/477748
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5174
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477748 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES | Apr 2, 2017 | Abandoned |
Array
(
[id] => 11755987
[patent_doc_number] => 20170202854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'Method for Treatment of Primary Hormone Resistant Endometrial and Breast Cancers'
[patent_app_type] => utility
[patent_app_number] => 15/476602
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17263
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476602 | Method for Treatment of Primary Hormone Resistant Endometrial and Breast Cancers | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14043343
[patent_doc_number] => 20190077778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHOD FOR PRODUCING ETHYLENE OXIDE
[patent_app_type] => utility
[patent_app_number] => 16/088748
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088748 | Method for producing ethylene oxide | Mar 29, 2017 | Issued |
Array
(
[id] => 15363471
[patent_doc_number] => 20200017500
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-16
[patent_title] => NOVEL CO-CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 16/090152
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090152 | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3',4':4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide | Mar 27, 2017 | Issued |
Array
(
[id] => 15363471
[patent_doc_number] => 20200017500
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-16
[patent_title] => NOVEL CO-CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 16/090152
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090152 | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3',4':4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide | Mar 27, 2017 | Issued |
Array
(
[id] => 16893455
[patent_doc_number] => 11034991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Methods to determine KDM1A target engagement and chemoprobes useful therefor
[patent_app_type] => utility
[patent_app_number] => 16/085024
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 43327
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085024 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | Mar 15, 2017 | Issued |
Array
(
[id] => 14043347
[patent_doc_number] => 20190077780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => Method for Preparing Halohydrin and Epoxide
[patent_app_type] => utility
[patent_app_number] => 16/085054
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085054 | Method for Preparing Halohydrin and Epoxide | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14817147
[patent_doc_number] => 10405553
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-10
[patent_title] => Antimicrobial articles and compounds therefor
[patent_app_type] => utility
[patent_app_number] => 15/453108
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10504
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453108
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453108 | Antimicrobial articles and compounds therefor | Mar 7, 2017 | Issued |
Array
(
[id] => 14102209
[patent_doc_number] => 20190092780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/083089
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083089 | Tricyclic compounds useful to treat orthomyxovirus infections | Mar 6, 2017 | Issued |
Array
(
[id] => 11704533
[patent_doc_number] => 20170173032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck'
[patent_app_type] => utility
[patent_app_number] => 15/450727
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13872
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450727 | Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck | Mar 5, 2017 | Issued |
Array
(
[id] => 11948167
[patent_doc_number] => 20170252319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Flavonoid-Poly(ethylene glycol) Complex Comprising Flavonoid Compounds and Poly(ethylene glycol) and Preparation Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/449011
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3978
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449011 | Flavonoid-Poly(ethylene glycol) Complex Comprising Flavonoid Compounds and Poly(ethylene glycol) and Preparation Method Thereof | Mar 2, 2017 | Abandoned |
Array
(
[id] => 13901669
[patent_doc_number] => 20190040039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => PIPERIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/079713
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079713 | Piperidine derivative | Feb 26, 2017 | Issued |
Array
(
[id] => 15281747
[patent_doc_number] => 10513528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Synthetic processes and intermediates
[patent_app_type] => utility
[patent_app_number] => 16/079469
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4495
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079469 | Synthetic processes and intermediates | Feb 22, 2017 | Issued |
Array
(
[id] => 16476195
[patent_doc_number] => 10851123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Prodrugs of phenolic TRPV1 agonists
[patent_app_type] => utility
[patent_app_number] => 16/078585
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43501
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078585 | Prodrugs of phenolic TRPV1 agonists | Feb 21, 2017 | Issued |
Array
(
[id] => 11669930
[patent_doc_number] => 20170158650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 15/435826
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21228
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435826 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | Feb 16, 2017 | Issued |
Array
(
[id] => 11949447
[patent_doc_number] => 20170253598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/435735
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42793
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435735 | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors | Feb 16, 2017 | Issued |
Array
(
[id] => 16492283
[patent_doc_number] => 10858307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Compositions and methods for treating liver cancer
[patent_app_type] => utility
[patent_app_number] => 15/999358
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4605
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999358
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999358 | Compositions and methods for treating liver cancer | Feb 15, 2017 | Issued |